Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Armata Pharmaceuticals, Inc. (ARMP : AMEX)

• Company Description    Armata Pharmaceuticals Inc. is a biotechnology company. It is focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. The company's principal product candidate consist AP-SA01, targets Staphylococcus aureus including multidrug-resistant strains. It is also developing and advancing a pipeline of synthetic phage candidates, including a synthetic phage for Pseudomonas aeruginosa. Armata Pharmaceuticals Inc., formerly known as AmpliPhi Biosciences Corporation, is based in Marina del Rey, California. Number of Employees: 61

• Price / Volume Information    Yesterday's Closing Price: $8.36 Daily Weekly Monthly 20 Day Moving Average: 85,023 shares Shares Outstanding: 36.71 (millions) Market Capitalization: $306.90 (millions) Beta: 1.31 52 Week High: $14.98 52 Week Low: $1.74 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.21% -41.23% 12 Week -22.81% -28.64% Year To Date 33.12% 20.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5005 MCCONNELL AVE - LOS ANGELES,CA 90066 USA ph: 310-665-2928 fax: 310-665-2963 ir@armatapharma.com http://www.armatapharma.com

• General Corporate Information    Officers Deborah Birx - Chief Executive Officer and Director Robin Kramer - Chairman David D. House - Senior Vice President; Finance and Principal Finan Jules Haimovitz - Director Odysseas D. Kostas - Director Peer Information Armata Pharmaceuticals, Inc. (CORR.) Armata Pharmaceuticals, Inc. (RSPI) Armata Pharmaceuticals, Inc. (CGXP) Armata Pharmaceuticals, Inc. (BGEN) Armata Pharmaceuticals, Inc. (GTBP) Armata Pharmaceuticals, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 04216R102 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/11/26 Share - Related Items Shares Outstanding: 36.71 Most Recent Split Date: 5.00 (0.07:1) Beta: 1.31 Market Capitalization: $306.90 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.48 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.88 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/11/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 59.00 EPS Growth vs. Year Ago Period: -95.00% vs. Previous Quarter: 23.53% Sales Growth vs. Year Ago Period: 60.69% vs. Previous Quarter: -27.28% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - -75.29 12/31/25 - -62.09 09/30/25 - -35.80 Current Ratio 03/31/26 - 0.64 12/31/25 - 1.19 09/30/25 - 0.12 Quick Ratio 03/31/26 - 0.64 12/31/25 - 1.19 09/30/25 - 0.12 Operating Margin 03/31/26 - -1,147.04 12/31/25 - -1,058.65 09/30/25 - -609.22 Net Margin 03/31/26 - -5,432.79 12/31/25 - -3,544.02 09/30/25 - -928.00 Pre-Tax Margin 03/31/26 - -5,432.79 12/31/25 - -3,544.02 09/30/25 - -928.00 Book Value 03/31/26 - -8.49 12/31/25 - -6.00 09/30/25 - -2.64 Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©